GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Total Assets

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Total Assets : ¥4,115.1 Mil (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Total Assets?

Beijing Bohui Innovation Biotechnology Group Co's Total Assets for the quarter that ended in Sep. 2024 was ¥4,115.1 Mil.

During the past 12 months, Beijing Bohui Innovation Biotechnology Group Co's average Total Assets Growth Rate was 5.20% per year. During the past 3 years, the average Total Assets Growth Rate was 1.20% per year. During the past 5 years, the average Total Assets Growth Rate was 8.80% per year. During the past 10 years, the average Total Assets Growth Rate was 25.80% per year.

During the past 13 years, Beijing Bohui Innovation Biotechnology Group Co's highest 3-Year average Total Assets Growth Rate was 100.10%. The lowest was 1.20%. And the median was 28.90%.

Total Assets is connected with ROA %. Beijing Bohui Innovation Biotechnology Group Co's annualized ROA % for the quarter that ended in Sep. 2024 was -0.39%. Total Assets is also linked to Revenue through Asset Turnover. Beijing Bohui Innovation Biotechnology Group Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.04.


Beijing Bohui Innovation Biotechnology Group Co Total Assets Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Total Assets Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,694.60 3,729.07 3,690.03 3,908.00 3,926.02

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,872.85 3,926.02 3,984.61 4,014.15 4,115.14

Beijing Bohui Innovation Biotechnology Group Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Beijing Bohui Innovation Biotechnology Group Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=2340.545+1585.47
=3,926.0

Beijing Bohui Innovation Biotechnology Group Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=2385.596+1729.54
=4,115.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Bohui Innovation Biotechnology Group Co  (SZSE:300318) Total Assets Explanation

Total Assets is connected with ROA %.

Beijing Bohui Innovation Biotechnology Group Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-15.664/( (4014.149+4115.136)/ 2 )
=-15.664/4064.6425
=-0.39 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Beijing Bohui Innovation Biotechnology Group Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=159.179/( (4014.149+4115.136)/ 2 )
=159.179/4064.6425
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Beijing Bohui Innovation Biotechnology Group Co Total Assets Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Executives
Niu Shu Hui Executives
Di Xiao Feng Director
Yang Qi Director
Lu Xin Qun Directors, executives
Zhang Lei Director
Wan Zhang Geng Executives
Song Rui Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines